Trading Signals: CEMI Stock Price Prediction and Forecast (Wed. Nov. 26, 2003 - Wed. Jul. 21, 2021)(Chembio Diagnostics Inc)
| CEMI latest price $5.3600 (-5.63%) ($5.2900 - $5.7400) on Tue. Aug. 11, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 10.37% (three month average) | RSI | 61 | Latest Price | $5.3600(-5.63%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CEMI declines -1.9% a day on average for past five trading days. | Weekly Trend | CEMI advances 4.2% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support CEMI advance at 0% a week (0% probability) TLT(36%) EWY(22%) LQD(22%) EEM(18%) VCIT(69%) | Factors Impacting CEMI price | CEMI will decline at least -5.185% in a week (0% probabilities). UUP(-29%) UNG(-24%) TBT(-20%) DRIV(-8%) TAN(-7%) | | | | | Relative Volatility | | | | Market Trend Strength | -5.185% (StdDev 10.37%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $5.58(-3.94%) | 10 Day Moving Average | $5.57(-3.77%) | 20 Day Moving Average | $5.35(0.19%) | To recent high | -57.2% | To recent low | 7.2% | Market Cap | $108m | | | | Chembio Diagnostics, Inc. develops, manufactures, markets and licenses rapid point-of-care diagnostic tests that detect infectious diseases. The firm expanding its product portfolio based upon the proprietary Dual Path Platform, which uses a small drop of blood from the fingertip to provide cost-effective diagnostic results in approximately 15 minutes. Its products include human and veterinary diagnostics. The company was founded in 1985 and is headquartered in Hauppauge, NY. |